Freedom Biosciences
Phase 3Freedom Biosciences is a leading biotechnology platform developing next-generation neuropsychiatric therapeutics.
Founded
2021
Focus
Psychedelics
About
Freedom Biosciences is a leading biotechnology platform developing next-generation neuropsychiatric therapeutics.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2021
LocationBoston, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile